A blunt defense of spinal cord stimulation that centers on evidence standards, trial limits, and device approval realities.
This episode pushes back on the habit of treating evidence criticism and industry funding as the same charge. It argues that spinal cord stimulation deserves tougher placebo and sham controlled studies, while also noting that those trials are costly and hard to run, especially…






